Inhibitory effect of tumor suppressor p33ING1b and its synergy with p53 gene in hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 11, Issue 13, 2005, Pages 1903-1909

  Zhu, Zhi ^a   Lin, Jing ^a   Qu, Jian Hui ^a   Feitelson, Mark A ^b   Ni, Can Rong ^a   Li, Fang Mei ^a   Zhu, Ming Hua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell cycle arrest; Gene p21waf1; Gene p33ING1b; Gene p53; Liver neoplasm

Indexed keywords

AGAR; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1; LIPOFECTAMINE; LUCIFERASE; PLASMID DNA; PROTEIN P33 ING1B; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CELL CLONING; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROTECTION; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ASSAY; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; PLASMID; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; RECOMBINANT GENE; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL SIGNIFICANCE; TUMOR GROWTH; WILD TYPE;

EID: 17144391516     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i13.1903     Document Type: Article

References (37)

1. ING1 promotes neoplastic transformation. Nat Genet 1996; 14: 415-420
2. ING1 promotes neoplastic transformation (correction). Nat Genet 1999; 23: 273
3. Garkavtsev I, Riabowol K. Extension of the replicative life span of human diploid fibroblasts by inhibition of the p33ING1 candidate tumor suppressor. Mol Cell Biol 1997; 17: 2014-2019
4. Vieyra D, Toyama T, Hara Y, Boland D, Johnston R, Riabowol K. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner. Cancer Res 2002; 62: 4445-4452
5. ING1 cooperates with p53 in cell growth control. Nature 1998; 391: 295-298
6. Zeremski M, Horrigan SK, Grigorian IA, Westbrook CA, Gudkov AV. Localization of the candidate tumor suppressor gene ING1 to human chromosome 13q34. Somat Cell Mol Genent 1997; 23: 233-236
7. Garkavtsev I, Demetrick D, Riabowol K. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene(ING1). Cytogenet Cell Genet 1997; 76: 176-178
8. Sanchez-Cespdes M, Okami K, Cairns P, Sidransky D. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions. Genes Chromosomes Cancer 2000; 27: 319-322
9. Oki E, Maehara Y, Tokunaga E, Kakeji Y, Sugimachi K. Reduced expression of p33(ING1) and the relationship with p53 expression in human gastric cancer. Cancer Lett 1999; 147: 157-162
10. Sarela AI, Farmery SM, Markham AF, Guillou PJ. The candidate tumour suppressor gene, ING1, is retained in colorectal carcinomas. Eur J Cancer 1999; 35: 1264-1267
11. Toyama T, Iwase H, Waston P, Muzik H, Saettler E, Magliocco A, DiFrancesco L, Forsyth P, Garkavtsev I, Kobayashi S, Riabowol K. Suppression of ING1 expression in sporadic breast cancer. Oncogene 1999; 18: 5187-5193
12. Tokunaga E, Maehara Y, Oki E, Kitamura K, Kakeji Y, Ohno S, Sugimachi K. Diminished expression of ING1 mRNA and the correlation with p53 expression in breast cancers. Cancer Lett 2000; 152: 15-22
13. Ohmori M, Nagai M, Tasaka T, Koeffler HP, Riabowol K, Takahara J. Decreased expression of p33ING1 mRNA in lymphoid malignancies. Am J Hematol 1999; 62: 118-119
14. Ito K, Kinjo K, Nakazato T, Ikeda Y, Kizaki M. Expression and sequence analyses of p33(ING1) gene in myeloid leukemia. Am J Hematol 2002; 69: 141-143
15. Nouman GS, Anderson JJ, Wood KM, Lunec J, Hall AG, Reid MM, Angus B. Loss of nuclear expression of the p33 (ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemia. J Clin Pathol 2002; 55: 596-601
16. Chen L, Matsubara N, Yoshino T, Nagasaka T, Hoshizima N, Shirakawa Y, Naomoto Y, Isozaki H, Riabowol K, Tanaka N. Genetic alterations of candidate tumor suppressor ING1 in human esophageal squamous cell cancer. Cancer Res 2001; 61: 4345-4349
17. Zeremski M, Hill JE, Kwek SS, Grigorian IA, Gurova KV, Garkavtsev IV, Diatchenko L, Koonin EV, Gudkov AV. Structure and regulation of the mouse ing1 gene. Three alternative transcripts encode two phd finger proteins that have opposite effects on p53 function. J Biol Chem 1999; 274: 32172-32181
18. Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K, Shimizu K. Genomic structure of the human ING1 gene and tumor specific mutations detected in head and neck squamous cell carcinomas. Cancer Res 2000; 60: 3143-3146
19. Greenblatt MS, Feitelson MA, Zhu MH, Bennett WP, Welsh JA, Jones R, Borkowski A, Harris CC. Integrity of p53 in hepatitis B × antigen- positive and negative hepatocellular carcinomas. Cancer Res 1997; 57: 426-432
20. Boland D, Olineck V, Bonnefin P, Vieyra D, Parr E, Riabowol K. A panel of CAb antibodies recognize endogenous and ectopically expressed ING1 protein. Hybridoma 2000; 19: 161-165
21. Garkavtsev I, Bolond D, Mai J, Wilson H, Veillette C, Riabowol K. Specific monoclonal antibody raised against the p33ING1 tumor suppressor. Hybridoma 1997; 16: 537-540
22. Puisieux A, Galvin K, Troalem F, Bressac B, Marcais C, Galun E, Ponchel F, Yakicier C, Ji J, Ozturk M. Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J 1993; 7: 1407-1413
23. (WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas. Hepatology 1997; 25: 575-579
24. Leung KM, Po LS, Tsang FC, Siu WY, Lan A, Ho HT, Poon RY. The candidate tumor suppressor ING1b can stabilize p53 by disrupting the regulation of p53 by MDM2. Cancer Res 2002; 62: 4890-4893
25. Lee SG, Rho HM. Transcriptional repression of the human p53 gene by hepatitis B viralx protein. Oncogene 2000; 19: 468-471
26. Shinoura N, Muramatsu Y, Nishimura M, Yoshida Y, Saito A, Yokoyama T, Furukawa T, Horii A, Hashimoto M, Asai A, Kirino T, Hamada H. Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas. Cancer Res 1999; 59: 5521-5528
27. Helbing CC, Veillette C, Riabowol K, Johnston RN, Garkavtsev I. A novel candidate tumor suppressor, ING1, is involved in the regulation of apoptosis. Cancer Res 1997; 57: 1255-1258
28. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408: 307-310
29. Ohgi T, Masaki T, Nakai S, Morishita A, Yukimasa S, Nagai M, Miyauchi Y, Funaki T, Kurokohchi K, Watanabe S, Kuriyama S. Expression of p33(ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity. Scand J Gastroenterol 2002; 37: 1440-1448
30. Zhu Z, Zhu M, Ni C. Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma. Zhonghua Yixue Zazhi 2002; 82: 1332-1336
31. Zhu Z, Lin J, Qu JH, Li FM, Ni CR, Zhu MH. Study of cooperation of tumor suppressor p33(ING1b) with p53 gene in hepatocellular carcinoma. Zhonghua Yixue Zazhi 2003; 83: 1795-1800
32. Lin J, Zhu MH, Zhu S, Qu JH, Li FM, Ni CR. The role of hepatitis B virus X gene and p53 on hepatosellular carcinoma cell growth. Zhonghua Binglixue Zazhi 2003; 32: 43-47
33. Vieyra D, Toyama T, Hara Y, Boland D, Johnston R, Riabowol K. ING1 isoforms differentially affect apoptosis in a cell age-dependent manner. Cancer Res 2002; 62: 4445-4452
34. Nouman GS, Anderson JJ, Wood KM, Lunec J, Hall AG, Reid MM, Angus B. Loss of nuclear expression of the p33(ING1b) inhibitor of growth protein in childhood acute lymphoblastic leukaemia. J Clin Pathol 2002; 55: 596-601
35. Vieyra D, Loewith R, Scott M, Bonnefin P, Boisvert FM, Cheema P, Pastyryeva S, Meijer M, Johnston RN, Bazett-Jones DP, McMahon S, Cole MD, Young D, Riabowol K. Human ING1 proteins differentially regulate histone acetylation. J Biol Chem 2002; 277: 29832-29839
36. Nouman GS, Angus B, Lunec J, Crosier S, Lodge A, Anderson JJ. Comparative assessment expression of the inhibitor of growth 1 gene (ING1) in normal and neoplastic tissues. Hybrid Hybridomics 2002; 21: 1-10
37. Campos EI, Cheung KJ Jr, Murray A, Li S, Li G. The novel tumour suppressor gene ING1 is overexpressed in human melanoma cell lines. Br J Dermatol 2002; 146: 574-580